Pheochromocytoma: First International Symposium, Volume 1073ISBN: 978-1-57331-597-5
Paperback
328 pages
August 2006, Wiley-Blackwell
|
Between 30 and 35% of the tumors have a hereditary basis.
Development of malignancy is highly variable -- from less than 5%
to more than 50% depending on the mutation; there is currently no
effective cure.
This volume encompasses a number of themes in several sections:
genetics and clinical decision-making; genetics, molecular pathways
of tumorigenesis, and divergent phenotypes; kaleidoscopic
presentations and a minefield for differential diagnosis of
pheochromocytoma; biochemical diagnosis: can we reach consensus?;
tumor localization and the evolving importance of functional
imaging; and new molecular markers and targets for diagnosis and
treatment of malignant pheochromcytoma.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member